WallStreetZenWallStreetZen

NASDAQ: SLNO
Soleno Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Soleno Therapeutics earnings were -$78.5M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest SLNO earnings report on Sep 30, 2025 announced Q3 2025 earnings of $26.0M, down 652.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SLNO reported annual earnings of -$175.9M, with 351% growth.

SLNO earnings history

Current Revenue
$98.7M
Current Earnings
-$78.5M
Current Profit Margin
-79.5%

SLNO Return on Equity

Current Company
-25.9%
Current Industry
-21.3%
Current Market
36.1%
SLNO's Return on Equity (-25.9%)... subscribe to Premium to read more.
High Return on Equity Performance

SLNO undefined

Current Company
-19.8%
Current Industry
-8.8%
SLNO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SLNO announces earnings.

SLNO undefined

Current Company
-13.08%
Current Industry
-3.4%
SLNO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SLNO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SLNO-$71.40M-$78.45MN/A-$1.85
APLS$93.37M$44.99MN/A$0.35
NUVB-$208.75M-$217.48MN/A-$0.49
EWTX-$154.92M-$157.24MN/A-$1.58
RCUS-$315.00M-$341.00MN/A-$3.44
View Top Biotech Stocks

Soleno Therapeutics Earnings Reports & History FAQ

What were Soleno Therapeutics's earnings last quarter?

On SLNO's earnings call on Invalid Date, Soleno Therapeutics (NASDAQ: SLNO) reported Q3 2025 earnings per share (EPS) of $0.49, up 126.78% year over year. Total SLNO earnings for the quarter were $26.01 million. In the same quarter last year, Soleno Therapeutics's earnings per share (EPS) was -$1.83.

If you're new to stock investing, here's how to buy Soleno Therapeutics stock.

Is Soleno Therapeutics profitable or losing money?

As of the last Soleno Therapeutics earnings report, Soleno Therapeutics is currently losing money. Soleno Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$78.45 million, a 40.19% decrease year over year.

What was SLNO's earnings growth in the past year?

As of Soleno Therapeutics's earnings date in Invalid Date, Soleno Therapeutics's earnings has grown year over year. SLNO earnings in the past year totalled -$78.45 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.